ChemicalBook > CAS DataBase List > N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide

N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide

Product Name
N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide
CAS No.
2044702-39-6
Chemical Name
N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide
Synonyms
Ostinib impurity 12;Osimertinib Impurity G;Osimertinib Impurity 25;AZD9291（Osimertinib） Impurity 12;N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide;2-Propenamide, N-[2-(dimethylamino)-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-
CBNumber
CB43158755
Molecular Formula
C25H26N6O2
Formula Weight
442.51
MOL File
2044702-39-6.mol
More
Less

N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide Property

Density 
1.22±0.1 g/cm3(Predicted)
pka
12.29±0.70(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P280Wear protective gloves/protective clothing/eye protection/face protection.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide Suppliers

China 30 India 2 Global 32
Shanghai SuperLan Chemcial Technique Centre
Tel
0-2022843681 15618226720
Fax
+86-21-51601218
Email
chaolaichem@foxmail.com
Country
China
ProdList
9955
Advantage
58
Shanghai XingTai Pharmaceutical Technology co., LTD
Tel
15801747407
Fax
+86 021 51388225
Email
sales01@suntechpharma.com
Country
China
ProdList
123
Advantage
58
Hubei Yangxin Medical Technology Co., Ltd.
Tel
15374522761
Fax
QQ:2853117752
Email
3003392093@yongstandards.com
Country
China
ProdList
9999
Advantage
55
Shanghai Han-Xiang Chemical Co., Ltd.
Tel
15971444841
Fax
18327183813
Email
amber@biochempartner.com
Country
China
ProdList
3061
Advantage
58
Shenzhen Polymeri Biochemical Technology Co., Ltd.
Tel
+86-400-002-6226 +86-13028896684;
Email
sales@rrkchem.com
Country
China
ProdList
57422
Advantage
58
Jinan Baizhou Biological Technology Co., Ltd.
Tel
0531-88987162 18615427082
Email
2823799053@qq.com
Country
China
ProdList
544
Advantage
58
Shenzhen Jianyi Biotechnology Co., Ltd
Tel
0755-84826604
Email
3001783715@qq.com
Country
CHINA
ProdList
2896
Advantage
58
Hubei Xinyang Medical Technology Co., Ltd
Tel
15347293736
Fax
QQ：2853117752
Email
2853117764@yongstandards.com
Country
China
ProdList
10000
Advantage
58
Shanghai Fulaiyide Pharmaceutical Technology Co., Ltd
Tel
19033008971 13182942551 19331071838
Email
wang666xt@163.com
Country
China
ProdList
473
Advantage
58
QUALITY CONTROL SOLUTIONS LTD.
Tel
+86-0755-66853366 +86-13670046396
Email
export03@qcsrm.com
Country
China
ProdList
24342
Advantage
58
More
Less

View Lastest Price from N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide manufacturers

ShenZhen H&D Pharmaceutical Technology Co., LTD
Product
AZD9291（Osimertinib） Impurity 12 2044702-39-6
Price
US $0.00-0.00/mg
Min. Order
10mg
Purity
0.98
Supply Ability
10g
Release date
2024-04-26

2044702-39-6, N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamideRelated Search:

Osimertinib Impurity M 4-fluoro-2-methoxy-3-nitrobenzenamine AZ 7550 1,4-Benzenediamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro- AZD-9291 3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide 1,2,4-Benzenetriamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]- Osimertinib mesylate 1,4-BenzenediaMine, N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]-2-nitro- Oxacillin Sodium Impurity D(EP) Oxacillin Sodium Impurity I(EP) Osimertinib Impurity N Oxacillin Sodium Impurity G(EP) AZ-5104 2-Propenamide, N-[2-[[2-(dimethyloxidoamino)ethyl]methyloxidoamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]- Osimertinib Impurity 3 Osimertinib Impurity 8 Osimertinib Impurity 2 DiHCl

  • N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide
  • Osimertinib Impurity G
  • Osimertinib Impurity 25
  • 2-Propenamide, N-[2-(dimethylamino)-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-
  • AZD9291（Osimertinib） Impurity 12
  • Ostinib impurity 12
  • 2044702-39-6